Children News and Research

RSS

FHI, Duke University Medical Center pertner to improve TB treatment

Family Health International, a nonprofit global health and development organization working to improve the lives of the world's most vulnerable people, recently joined the Tuberculosis Trials Consortium, an international body that researches new TB drugs and treatment strategies. The consortium is funded by the US Centers for Disease Control and Prevention. As part of the consortium, FHI is partnering with Duke University Medical Center to conduct clinical trials that aim to reduce the duration of TB treatment and lessen the side effects of TB drugs.

24 Mar 2010

Consumers choose indulgent food items while shopping for others

Feel like Mom is pushing dessert? According to a new study in the Journal of Consumer Research, consumers choose foods that are less healthy when they are purchasing for others.

24 Mar 2010

Pharmaceutical firms, GAVI Alliance agree to provide long-term supply of Pneumococcal vaccine

Millions of infants and young children in the world's poorest countries will receive potentially life-saving vaccines that help protect against pneumococcal disease, including pneumonia -- the world's biggest childhood killer, thanks to new agreements made with two major pharmaceutical firms, the GAVI Alliance announced today.

24 Mar 2010

Gentium presents abstract on Defibrotide at EBMT Annual Meeting

Gentium S.p.A.today announced that the abstract titled, "Defibrotide prevents hepatic VOD and reduces significantly VOD-associated complications in children at high risk: final results of a prospective phase II/III multicenter study," was presented on Sunday, March 21, 2010, at the opening session of the European Blood and Marrow Transplantation 36th Annual Meeting in Vienna. The abstract received the esteemed Van Bekkum Award for the best abstract submitted to the physician's program. Dr. Selim Corbacioglu, Professor of Pediatrics, University of Regensburg (Germany) and Principal Investigator of the Pediatric Prevention trial, accepted the award and presented the final results of the study.

24 Mar 2010

Vaccine deal signed - 47 developing countries to receive low priced vaccines by 2015

Pharmaceutical giants have signed a historical 10-year deal on Tuesday pledging the supply of 60 million doses a year of pneumococcal vaccines at cut-prices to developing nations.

24 Mar 2010

MHPA commends Congress for improving state Medicaid programs

"Congress has made a historical commitment to providing access to health care for 16 million low-income Americans through expansion of the Medicaid program. The bills also maintain and strengthen health coverage for kids through the Children's Health Insurance Program."

24 Mar 2010

Research shows single women still face social stigma

In 2009, approximately 40 percent of adults were single, according to the U.S. Census Bureau. In a new study, "I'm a Loser, I'm Not Married, Let's Just All Look at Me," a University of Missouri researcher examined the familial and societal messages given to women who are not married by their mid-30's.

24 Mar 2010

FDA recommends clinicians temporarily suspend use of Rotarix vaccine

The agency recently became aware that an independent U.S. academic research team, using a novel technique, has found DNA from porcine circovirus 1 (PCV1) in Rotarix, which is manufactured by GlaxoSmithKline. PCV1 is not known to cause illness in humans or other animals. In addition, Rotarix has been studied extensively, before and after approval, and found to have an excellent safety record.

24 Mar 2010

Washington State mercury-limit suspension for swine flu vaccine ends

When it comes to some diseases prevention still is better than cure and swine flu is one such disease. The sheer global panic that gripped nations last year is hard to forget. The PanvaxH1N1 vaccine is specifically manufactured to target the influenza (A) H1N1 strain known more popularly as swine flu. Getting the flu shots may be crucial in prevention of spread of the highly contagious disease. Health officials say that the H1N1 strain of flu is still circulating but at low levels.

24 Mar 2010

GSK joins GAVI Alliance in the Pneumococcal disease vaccine drive

GSK has become one of the first manufacturers to sign a unique agreement with the GAVI Alliance that has the potential to save millions of children from dying in the world's poorest countries. GSK will supply up to 300 million doses of its vaccine Synflorix, for invasive pneumococcal disease, to GAVI over a ten year period. Pneumococcal disease is a leading cause of death in children under the age of five in developing countries.

24 Mar 2010

GENETICS 2010 meeting highlights latest research on human genetic disorders

The Genetics Society of America (GSA) biennial meeting, "GENETICS 2010: Model Organisms to Human Biology," June 12-15, 2010, at the Sheraton Boston, Massachusetts, will bring together investigators who study genetic models in organisms such as flies, yeast, fungi, mice and other non-human organisms, with researchers in human genetics

24 Mar 2010

State roundup: Arizona repeals CHIP program, Conn. insurance pool, Minnesota boosted by health bill

The Associated Press: "A controversial decision by Arizona lawmakers to eliminate a health insurance program for poor children puts it at risk of losing billions of dollars in federal Medicaid funding under the historic health care bill approved by Congress. Arizona last week became the first state to eliminate its Children's Health Insurance Program, removing an estimated 38,000 kids from the rolls starting in June in a budget-cutting move by Gov. Jan Brewer and the Republican-led Legislature. ... Rep. Kyrsten Sinema, D-Phoenix, told Brewer and House Speaker Kirk Adams in separate letters that eliminating the state's KidsCare program on June 15 would violate a 'maintenance of effort' requirement of the Senate health care overhaul bill approved by Congress" (Davenport, 3/22).

24 Mar 2010

Opinion: Repurposing wastewater; expanding global fund; financing global health needs

In an Economic Times opinion piece, Jeffrey Sachs of the Earth Institute at Columbia University outlines what he sees as "two huge challenges facing" the Global Fund to Fight AIDS, Tuberculosis and Malaria:

24 Mar 2010

Bioalliance Pharma's anti-emetic drug Setofilm receives European approval

BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announced approval for Setofilm® in 16 European countries.

24 Mar 2010

Obama and Congress deliver meaningful healthcare reform

Alliance President and CEO joins President Obama, Members of Congress, and leading health advocates at President's speech marking signing of health insurance reform into law

24 Mar 2010

WHO advises continued use of GSK's rotavirus vaccine in developing countries

The WHO on Monday advised developing countries to continue administering GlaxoSmithKline's Rotarix vaccine - which offers protection to children against the diarrhea-causing rotavirus - after the FDA advised doctors in the U.S. to temporarily stop using the vaccine following the discovery that it was "contaminated with an apparently harmless pig virus," Reuters reports

24 Mar 2010

FDA grants Orphan Drug Designation for anti-diabetic drug

The FDA has granted Orphan Drug Designation of Diamyd Medical´s lead drug candidate Diamyd®. Orphan drugs qualify for seven years of market exclusivity from the date of US marketing approval, tax credits for clinical research and a waiver for FDA user fees.

24 Mar 2010